Cleerly Coronary AI (Cleerly Platform) vs Prognos Platform
AI-enhanced independent comparison — features, pros, cons, pricing and rankings.
| Dimension | Cleerly Coronary AI (Cleerly Platform) | Prognos Platform |
|---|---|---|
| Accuracy & Reliability | ||
| Ease of Use | ||
| Features & Capability | ||
| Value for Money | ||
| Performance & Speed | ||
| Popularity & Adoption |
Who each tool serves best — and when to pick the other one.
Cardiologists and radiologists seeking objective, detailed coronary artery disease analysis integrated into clinical workflows.
- You need precise quantification of coronary artery disease from CT scans for clinical decisions.
- You want to integrate advanced imaging analysis seamlessly into existing cardiology workflows.
- Your team requires reproducible and objective coronary artery disease visualization for treatment planning.
Healthcare providers without access to coronary CT angiograms or those needing broad diagnostic imaging beyond coronary artery disease.
- You need AI tools for general medical imaging beyond coronary artery disease.
- Free-tier limits are a blocker for your clinical volume or feature needs.
- You require public API access for custom integrations or automation.
Accuracy and clinical integration for coronary artery disease quantification from CT angiograms.
Healthcare providers and payers seeking to predict patient disease risk and improve treatment outcomes using clinical and lab data analytics.
- You need to identify high-risk patients using real-world clinical data analytics.
- You want to improve treatment outcomes through predictive disease modeling.
- Your team requires integration of lab data with clinical decision support workflows.
Small clinics or providers without access to large clinical datasets or those needing simple, standalone diagnostic tools.
- You need a simple diagnostic tool without complex data integration.
- Free-tier limits are a blocker for your organization's scale and data volume.
- You require a fully open-source or self-hosted solution.
The ability to leverage large-scale clinical and lab data for precise risk prediction and decision support.
A canonical comparison across capabilities common to this category. Vendor-specific extras appear below in "Highlighted Features".
| Capability | Cleerly Coronary AI (Cleerly Platform) | Prognos Platform |
|---|---|---|
|
Free Tier Available
Usable without payment (with usage limits)
|
✓ | ✓ |
Each tool's marketing-listed features. Where a feature appears under one tool but not the other, it usually reflects how the vendor describes their product — not a definitive capability gap.
- Coronary CT Angiogram Analysis — Quantifies and visualizes coronary artery disease severity
- Clinical workflow integration — Integrates with cardiology and radiology clinical workflows
- Objective Disease Quantification — Provides reproducible and objective insights for diagnosis
- Visualization tools — Visualizes artery disease severity in detail
- Advanced Reporting — Generates detailed reports for clinical decision support
- Disease Risk Prediction — Predicts patient disease risk using clinical and lab data
- Treatment Outcome Forecasting — Estimates likely treatment outcomes for patients
- Large-scale Data Integration — Combines extensive lab and clinical datasets
- Clinical Decision Support — Supports healthcare providers in patient management
- Population Health Analytics — Analyzes health trends across patient populations
- Accurate and reproducible coronary artery disease quantification
- Clear visualization of artery disease severity
- Seamless integration with clinical workflows
- Designed specifically for cardiology and radiology professionals
- Supports improved diagnosis and treatment planning
- Integrates large-scale clinical and lab data effectively
- Provides actionable disease risk predictions
- Supports payer and provider healthcare workflows
- Scalable for population health management
- Limited publicly available pricing details
- No public API for custom integrations
- Focused solely on coronary artery disease, not broader imaging
- Limited public pricing and plan details
- No publicly documented API access
- Potential complexity in integrating with existing systems
- Quantifying coronary artery disease severity from CT scans
- Supporting cardiologists in diagnosis and treatment planning
- Enhancing radiology workflow with automated analysis
- Visualizing artery disease for patient consultations
- Improving reproducibility in coronary imaging assessments
- Identifying high-risk patients for chronic diseases
- Predicting treatment outcomes for personalized care
- Supporting payer risk stratification and management
- Enhancing clinical decision-making with lab data insights
- Population health management and analytics
Where each tool runs — web, mobile, desktop, browser extension, API.
Natural languages each tool generates and understands. Primary languages are listed first.
What each tool can accept (input) and produce (output) — text, image, audio, video, code.
Offers a freemium pricing model with basic features available for free; advanced capabilities and higher usage may require paid plans.
-
Free
Free
Offers a freemium pricing model with a free tier and paid plans; detailed pricing is not publicly disclosed.
-
Free
Free
Regulatory frameworks each tool claims compliance with (HIPAA, SOC 2, GDPR, etc.).
Third-party audits and certifications that verify security controls.
Vendor-published numbers each tool highlights — usage scale, breadth, and operational stats. Different tools track different metrics, so direct row-by-row comparison usually isn't meaningful.
- Accuracy High precision in coronary artery disease quantifi
- Integration Seamless clinical workflow compatibility
- Data Scale Millions of clinical and lab records
- Prediction Accuracy High
How you can reach support — email, live chat, phone, community, docs.
- Email primary
- Email primary
How each tool is classified in the Volvenix catalog.
These vocabulary domains are managed in our catalog but not yet exposed at the tool level. We're tracking them for future expansion of this comparison.
- Encryption Types — AES-256, ChaCha20, RSA-2048, and similar at-rest/in-transit cipher families.
- Encryption Contexts — where encryption is applied (data at rest, in transit, end-to-end).
- Plan-tier Model Mapping — which AI models are available on which pricing tier (currently only the model list is tracked, not the per-plan availability).
- What is this tool?
- Cleerly Coronary AI analyzes coronary CT angiograms to quantify and visualize coronary artery disease severity for clinical use.
- How much does it cost?
- Cleerly offers a freemium pricing model with basic features free; advanced features may require paid plans.
- Does it have a free plan?
- Yes, a free plan is available with basic coronary CT scan analysis features.
- What integrations does it support?
- It integrates with clinical cardiology and radiology workflows; no public API or third-party integrations are documented.
- Who is it best for?
- It is best suited for cardiologists and radiologists needing objective coronary artery disease analysis.
- What is this tool?
- Prognos Platform predicts disease risk and treatment outcomes using clinical and lab data for healthcare providers and payers.
- How much does it cost?
- It offers a freemium pricing model with a free tier; detailed paid pricing is not publicly disclosed.
- Does it have a free plan?
- Yes, a free plan is available for basic access and evaluation.
- What integrations does it support?
- No public information on specific integrations is available.
- Who is it best for?
- Healthcare providers and payers seeking predictive analytics for clinical decision support.
| Info | Cleerly Coronary AI (Cleerly Platform) | Prognos Platform |
|---|---|---|
| Pricing | Freemium | Freemium |
| Category | Healthcare & Medical AI | Healthcare & Medical AI |
| Deployment | Cloud | Cloud |
| Free Plan | ✓ | ✓ |
| AI Agent | ✗ | ✗ |
Prognos Platform and Cleerly Coronary AI (Cleerly Platform) both offer freemium pricing models and have similar overall scores, with Prognos at 5.3/10 and Cleerly at 5.5/10. Prognos Platform primarily focuses on broad healthcare data analytics and predictive insights across various medical conditions, while Cleerly Coronary AI specializes in advanced coronary artery disease detection and cardiovascular imaging analysis. Their differing feature sets reflect these use case distinctions, with Prognos emphasizing population health management and Cleerly targeting detailed cardiac diagnostics.
ⓘ How Volvenix scores work
Scores are computed by Volvenix — not supplied by the vendors, and not third-party benchmark results. Each 0–10 dimension (Overall, Features, Usability, Support, Pricing) is a directional estimate aggregated from catalog signals — editorial cataloguing, content depth, engagement, and provider-reputation indicators — so treat them as a starting point, not a lab result.
Confidence reflects how complete the underlying data is for both tools; lower confidence means fewer signals were available, not a worse tool. We never accept payment for rankings or scores. More about how Volvenix works →